GlaxoSmithKline signs $43m deal with AI start-up
Scottish AI start-up Exscientia has signed a lucrative deal with a second pharmaceutical giant, as the benefits of artificial intelligence in drug research become apparent
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed